Featured Research

from universities, journals, and other organizations

Chemical Compounds Restore Normal Glucose Levels And Insulin Action In Obese Mice

Date:
August 24, 2006
Source:
Harvard School of Public Health
Summary:
Treatment of obese and diabetic mice with compounds that act as chemical chaperones called PBA and TUDCA restored healthy glucose levels and normal insulin action and reduced the presence of fatty liver disease, according to a study published in the August 25 issue of Science. The work was conducted by a team of researchers from the Harvard School of Public Health (HSPH).

Treatment of obese and diabetic mice with compounds that act as chemical chaperones called PBA and TUDCA restored healthy glucose levels and normal insulin action — and reduced the presence of fatty liver disease — according to a study published in the August 25 issue of Science. The work was conducted by a team of researchers from the Harvard School of Public Health (HSPH).

Related Articles


Type 2 diabetes – 90 to 95 percent of all diabetes cases – affects an estimated 18 million people in the United States, and causes some 200,000 deaths a year. Obesity is closely associated with insulin resistance and is one of the leading risk factors for type 2 diabetes. The molecular mechanisms that link these two metabolic diseases remain under investigation, and current therapeutic options are limited.

Gφkhan S. Hotamisligil, chair of the HSPH Department of Genetics and Complex Diseases, is the senior author of the Science paper. In 2004, he led a team that identified a major molecular pathway that causes diabetes. A cornerstone of that discovery was a hypothesis that the key to the obesity-diabetes connection might be found in the endoplasmic reticulum, or ER – a system of folded membranes and tubules in the cytoplasm of cells where proteins and lipids are manufactured, processed, and shipped around the cell. When unusual demands — such as excess fat — are put on the ER’s capacity, the organelle starts failing, and the cell enters an emergency mode, emitting stress signals. The condition is called ER stress. Cellular inflammation, insulin resistance and diabetes result. (http://www.hsph.harvard.edu/press/releases/press10142004.htm).

Hotamisligil’s team also previously identified the JNK gene as a key component linking inflammation to metabolic signaling and as a gene that interferes with insulin sensitivity. (http://www.hsph.harvard.edu/press/releases/press11202002b.html. ER stress appears to trigger abnormal JNK activity, which is often seen in obesity and type 2 diabetes.

In the new Science paper, Hotamisligil; lead author Umut Φzcan, a postdoctoral fellow; and their co-authors first identified compounds that alleviate ER stress in cellular models and demonstrated how two of these chemicals — PBA (4-phenyl butyric acid) and TUDCA (taurine-conjugated derivative) — reduced ER stress, prevented JNK activation, and restored normal glucose homeostasis in type 2 diabetic mice.

The researchers used the ob/ob murine model, where mice are both severely obese and insulin resistant. Oral administration of PBA (1 g per kg of body weight) was given to seven- to eight-week-old male ob/ob mice and to leaner, wild-type mice for 20 days. PBA reduced blood glucose levels in the ob/ob mice to those of their wild-type counterparts within four days; the levels were maintained for up to three weeks and were not associated with changes in body weight. PBA treatment also improved glucose tolerance in ob/ob mice, reduced the indicators of ER stress, and prevented JNK activation and suppression of insulin action in peripheral tissues.

Administration of TUDCA in a different set of ob/ob and wild-type mice normalized blood glucose levels within one week of treatment of the obese mice. TUDCA helped improve insulin response by reducing ER stress and suppressing JNK gene activation.

TUDCA and PBA treatment also appeared to interfere with the storage of fat in the liver, significantly reducing the presence of fatty liver disease -- a condition closely related to obesity and insulin resistance. One form of this disease — nonalcoholic steatohepatitis — is associated with inflammation and the creation of fibrous tissue, which can lead to cirrhosis.

PBA has been approved by the U.S. Food and Drug Administration for clinical use in urea-cycle disorders in humans. TUDCA has been used as a liver-protecting agent in human cholestatic liver diseases.

“Already used safely in people for some disorders, these compounds and others like them may warrant clinical investigation into their effects on type 2 diabetes in humans,” said Hotamisligil. “If these compounds work in humans as they do in experimental models, they could dramatically change the approaches to treat many components of metabolic syndrome.”

Researchers on this study are supported by grants from the National Institutes of Health, Japan Society for the Promotion of Science, and American Diabetes Association.


Story Source:

The above story is based on materials provided by Harvard School of Public Health. Note: Materials may be edited for content and length.


Cite This Page:

Harvard School of Public Health. "Chemical Compounds Restore Normal Glucose Levels And Insulin Action In Obese Mice." ScienceDaily. ScienceDaily, 24 August 2006. <www.sciencedaily.com/releases/2006/08/060824221949.htm>.
Harvard School of Public Health. (2006, August 24). Chemical Compounds Restore Normal Glucose Levels And Insulin Action In Obese Mice. ScienceDaily. Retrieved April 25, 2015 from www.sciencedaily.com/releases/2006/08/060824221949.htm
Harvard School of Public Health. "Chemical Compounds Restore Normal Glucose Levels And Insulin Action In Obese Mice." ScienceDaily. www.sciencedaily.com/releases/2006/08/060824221949.htm (accessed April 25, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, April 25, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

85 Killed in Niger by Meningitis Since Start of Year

85 Killed in Niger by Meningitis Since Start of Year

AFP (Apr. 24, 2015) — A meningitis outbreak in Niger has killed 85 people since the start of the year prompting authorities to close schools in the capital Niamey until Monday. Video provided by AFP
Powered by NewsLook.com
C-Section Births a Trend in Brazil

C-Section Births a Trend in Brazil

AFP (Apr. 24, 2015) — More than half of Brazil&apos;s babies are born via cesarean section, as mothers and doctors opt for a faster and less painful experience despite the health risks. Duration: 02:02 Video provided by AFP
Powered by NewsLook.com
Anti-Malaria Jab Hope

Anti-Malaria Jab Hope

Reuters - News Video Online (Apr. 24, 2015) — The world&apos;s first anti-malaria vaccine could get the go-ahead for use in Africa from October if approved by international regulators. Paul Chapman reports. Video provided by Reuters
Powered by NewsLook.com
3D Food Printing: The Meal of the Future?

3D Food Printing: The Meal of the Future?

AP (Apr. 23, 2015) — Developers of 3D food printing hope the culinary technology will revolutionize the way we cook and eat. (April 23) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins